Get the Stockscreener App
31.60
1.63%
0.56
Harrow Inc stock is traded at $31.60, with a volume of 107.26K.
It is up +1.63% in the last 24 hours and down -12.42% over the past month.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.
See More
Previous Close:
$31.04
Open:
$31.02
24h Volume:
107.26K
Relative Volume:
0.25
Market Cap:
$1.11B
Revenue:
$154.15M
Net Income/Loss:
$-33.58M
P/E Ratio:
-32.92
EPS:
-0.96
Net Cash Flow:
$-20.74M
1W Performance:
+2.69%
1M Performance:
-12.42%
6M Performance:
+43.52%
1Y Performance:
+219.60%
1-Day Range:
$30.57
$31.84
1-Week Range:
$28.96
$32.97
52-Week Range:
$9.30
$59.23
Harrow Inc Stock (HROW) Company Profile
Name
Harrow Inc
Sector
Phone
615.733.4731
Address
102 WOODMONT BLVD, NASHVILLE, CA
Compare HROW with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
31.54 | 1.11B | 154.15M | -33.58M | -20.74M | -0.96 |
|
ZTS
Zoetis Inc
|
171.81 | 78.56B | 9.15B | 2.43B | 2.31B | 5.32 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.55 | 43.15B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
9.535 | 43.00B | 14.26B | 1.55B | 0 | 0.3383 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.75 | 19.59B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
122.03 | 15.24B | 2.24B | 385.90M | 440.10M | 3.73 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-04-24 | Reiterated | B. Riley Securities | Buy |
| Apr-11-24 | Initiated | Craig Hallum | Buy |
| Sep-08-22 | Resumed | B. Riley Securities | Buy |
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Sep-24-21 | Initiated | Aegis Capital | Buy |
| Jul-02-21 | Initiated | Ladenburg Thalmann | Buy |
View All
Harrow Inc Stock (HROW) Latest News
HC Wainwright & Co. Initiates Coverage of Harrow (HROW) with Buy Recommendation - MSN
H.C. Wainwright sets $57 target on Harrow Health stock - Investing.com India
This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
HC Wainwright Begins Coverage on Harrow (NASDAQ:HROW) - MarketBeat
15,448 Shares in Harrow, Inc. (NASDAQ:HROW) Acquired by Sonora Investment Management Group LLC - MarketBeat
Harrow (NASDAQ:HROW) Stock Price Down 4.6%Here's What Happened - MarketBeat
Fungal Keratitis Treatment Market Growth By 2031 | Harrow Inc., - openPR
SG Americas Securities LLC Acquires 18,815 Shares of Harrow, Inc. (NASDAQ:HROW) - MarketBeat
SG Americas Securities LLC Boosts Stake in Harrow, Inc. (NASDAQ:HROW) - Defense World
Commit To Buy Harrow At $23, Earn 18% Annualized Using Options - Nasdaq
Nicox Announces Scientific Presentation and Conference Attendance in H1 2025 - GlobeNewswire Inc.
Opaleye management sells $711,814 worth of Harrow shares - MSN
Harrow Partners with Cencora to Launch “Harrow Cares” Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their Patients - Business Wire
Harrow Launches 'Harrow Cares' Patient Support Program with Cencora Partnership - StockTitan
Harrow, Inc. (NASDAQ:HROW) Sees Board Member Resignation - Defense World
Opaleye Management Inc. Significantly Reduces Stake in Harrow Inc. - GuruFocus.com
Opaleye management sells $711,814 worth of Harrow shares By Investing.com - Investing.com Australia
Harrow (NASDAQ:HROW) Trading Down 4.9%Time to Sell? - MarketBeat
Assenagon Asset Management S.A. Sells 79,071 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World
Harrow, Inc. (NASDAQ:HROW) Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Brookstone Capital Management Invests $275,000 in Harrow, Inc. (NASDAQ:HROW) - Defense World
Brookstone Capital Management Purchases New Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow (NASDAQ:HROW) Stock Price Down 4.1%Should You Sell? - MarketBeat
JPMorgan Chase & Co. Purchases 194,480 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World
Harrow, Inc. (NASDAQ:HROW) Shares Acquired by JPMorgan Chase & Co. - MarketBeat
Harrow appoints new Chief Scientific Officer - Investing.com
Harrow announces Amir Shojaei, PharmD, PhD joins as CSO - TipRanks
Harrow Appoints Amir H. Shojaei as Chief Scientific Officer - Business Wire
Principal Financial Group Inc. Takes Position in Harrow, Inc. (NASDAQ:HROW) - Defense World
Harrow Inc (NASDAQ: HROW): On Track To A Higher Share Price - Stocks Register
Those Derisked Baby Bonds Of Harrow, Inc (NASDAQ:HROWM) - Seeking Alpha
Harrow (NASDAQ:HROW) Shares Up 7.7%Should You Buy? - MarketBeat
Franklin Resources Inc. Reduces Stock Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow (HROW) is on the Move, Here's Why the Trend Could be Sustainable - MSN
Harrow Inc (HROW) Stock Price Down 4.85% on Dec 27 - GuruFocus.com
Oversold Conditions For Harrow (HROW) - Nasdaq
Geode Capital Management LLC Buys 3,960 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World
Barclays PLC Buys 39,506 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World
Barclays PLC Boosts Stake in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow (NASDAQ:HROW) Stock Price Down 2.5%Here's What Happened - MarketBeat
3 US Growth Stocks With Insider Ownership Expecting Up To 85% Earnings Growth - Yahoo Finance
HighTower Advisors LLC Sells 1,575 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World
State Street Corp Has $32.87 Million Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow’s Valuation Hinges On Lofty Growth Amid Persistent Financial Strains (NASDAQ:HROW) - Seeking Alpha
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires Shares of 32,678 Harrow, Inc. (NASDAQ:HROW) - MarketBeat
The Manufacturers Life Insurance Company Lowers Position in Harrow, Inc. (NASDAQ:HROW) - Defense World
Harrow Stock: The Triesence Relaunch (NASDAQ:HROW) - Seeking Alpha
Harrow Inc Stock (HROW) Financials Data
Revenue
Net Income
Cash Flow
EPS
Harrow Inc Stock (HROW) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SAHAREK JOHN P. | CEO of ImprimisRx |
Sep 11 '24 |
Option Exercise |
7.37 |
90,000 |
663,300 |
344,803 |
| Opaleye Management Inc. | 10% Owner |
Apr 25 '24 |
Buy |
9.97 |
20,000 |
199,400 |
3,815,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 23 '24 |
Buy |
10.29 |
11,715 |
120,547 |
3,786,715 |
| Opaleye Management Inc. | 10% Owner |
Apr 24 '24 |
Buy |
10.15 |
8,285 |
84,093 |
3,795,000 |
| Opaleye Management Inc. | 10% Owner |
Apr 19 '24 |
Buy |
10.56 |
29,400 |
310,390 |
3,775,000 |
| Opaleye Management Inc. | 10% Owner |
Mar 28 '24 |
Buy |
12.82 |
50,000 |
641,000 |
3,745,600 |
| BAUM MARK L | CHIEF EXECUTIVE OFFICER |
Mar 22 '24 |
Buy |
11.59 |
9,000 |
104,310 |
2,137,525 |
| Opaleye Management Inc. | 10% Owner |
Mar 20 '24 |
Buy |
9.65 |
50,600 |
488,290 |
3,695,600 |
| SAHAREK JOHN P. | CEO of ImprimisRx |
Mar 01 '24 |
Option Exercise |
8.75 |
5,000 |
43,750 |
254,803 |
| SAHAREK JOHN P. | CEO of ImprimisRx |
Feb 20 '24 |
Option Exercise |
10.67 |
30,000 |
320,100 |
262,419 |
0.70%
2.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):